Men and women differ in their diurnal expression of monocyte peroxisome proliferator-activated receptor-α in the fed but not in the fasted state

被引:11
|
作者
Wege, Nicole [1 ]
Schutkowski, Alexandra [1 ]
Boenn, Markus [2 ,4 ]
Bialek, Joanna [1 ]
Schlitt, Axel [3 ,5 ]
Noack, Frank [3 ]
Grosse, Ivo [2 ,6 ]
Stangl, Gabriele I. [1 ]
机构
[1] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06120 Halle, Germany
[2] Univ Halle Wittenberg, Inst Comp Sci, D-06120 Halle, Germany
[3] Univ Halle Wittenberg, Univ Clin Halle Saale, D-06120 Halle, Germany
[4] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany
[5] Paracelsus Harz Clin Bad Suderode, Quedlinburg, Germany
[6] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany
关键词
caloric intake; nuclear receptor; circadian pacemaker; PPAR-ALPHA; THERAPEUTIC TARGET; SEXUAL SELECTION; ANGIOGENESIS; INVOLVEMENT; METABOLISM; MUSCLE; CLOCK; MODEL;
D O I
10.1096/fj.14-267575
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator-activated receptor-alpha (PPAR alpha) plays a pivotal role in regulating metabolic response to fasting and is an inhibitor of inflammatory pathways in immune cells. It represents a therapeutic target for treatment of several diseases, mainly hyperlipidemia. To shed light on PPAR alpha expression changes in response to fasting, young healthy male and female volunteers were fed or fasted for 24 hours. Monocytes were analyzed every 2 hours to compile both profiles of mRNA and protein expression of PPAR alpha and its interactive partner, the circadian pacemaker brain and muscle aryl hydrocarbon receptor nuclear translocator like-1 (BMAL1). We found that women change their diurnal expression profiles of PPAR alpha and BMAL1 when switching from the fed to the fasted state, whereas men do not. Interestingly, the PPAR alpha and BMAL1 profiles of men and women in the fed state are different, whereas the profiles in the fasted state are virtually identical. The finding of diametrically opposite responses of male and female PPAR alpha expression in the fed state might have practical implication in human medicine as PPAR alpha activators like fibrates are used for the therapy of chronic lymphocytic leukemia, microvascular complications in diabetes, and kidney diseases.
引用
收藏
页码:2905 / 2911
页数:7
相关论文
共 50 条
  • [31] Modulating Effects of Chlorogenic Acid on Lipids and Glucose Metabolism and Expression of Hepatic Peroxisome Proliferator-activated Receptor-α in Golden Hamsters Fed on High Fat Diet
    Li, Shu-Yuan
    Chang, Cui-Qing
    Ma, Fu-Ying
    Yu, Chang-Long
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2009, 22 (02) : 122 - 129
  • [32] Activation of peroxisome proliferator-activated receptor-α in mice induces expression of the hepatic low-density lipoprotein receptor
    Huang, Z.
    Zhou, X.
    Nicholson, A. C.
    Gotto, A. M., Jr.
    Hajjar, D. P.
    Han, J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 155 (04) : 596 - 605
  • [33] Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma
    Bo, Qi-Fu
    Sun, Xiu-Mei
    Liu, Jin
    Sui, Xiao-Mei
    Li, Gui-Xin
    ONCOLOGY LETTERS, 2015, 10 (04) : 1979 - 1984
  • [34] Activation of intestinal peroxisome proliferator-activated receptor- increases high-density lipoprotein production
    Colin, Sophie
    Briand, Olivier
    Touche, Veronique
    Wouters, Kristiaan
    Baron, Morgane
    Pattou, Francois
    Hanf, Remy
    Tailleux, Anne
    Chinetti, Giulia
    Staels, Bart
    Lestavel, Sophie
    EUROPEAN HEART JOURNAL, 2013, 34 (32) : 2566 - +
  • [35] Peroxisome Proliferator-Activated Receptor-α Contributes to the Resolution of Inflammation after Renal Ischemia/Reperfusion Injury
    Patel, Nimesh S. A.
    di Paola, Rosanna
    Mazzon, Emanuela
    Britti, Domenico
    Thiemermann, Christoph
    Cuzzocrea, Salvatore
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (02) : 635 - 643
  • [36] Peroxisome Proliferator-Activated Receptor-α Inhibition Protects Against Doxorubicin-Induced Cardiotoxicity in Mice
    Rahmatollahi, Mahdieh
    Baram, Somayeh Mahmoodi
    Rahimian, Reza
    Saravi, Seyed Soheil Saeedi
    Dehpour, Ahmad Reza
    CARDIOVASCULAR TOXICOLOGY, 2016, 16 (03) : 244 - 250
  • [37] Leukotriene B4 Is a Physiologically Relevant Endogenous Peroxisome Proliferator-activated Receptor-α Agonist
    Narala, Venkata R.
    Adapala, Ravi K.
    Suresh, Madathilparambil V.
    Brock, Thomas G.
    Peters-Golden, Marc
    Reddy, Raju C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (29) : 22067 - 22074
  • [38] Peroxisome proliferator-activated receptor-γ activation attenuates harmaline-induced cognitive impairments in rats
    Aghaei, Iraj
    Hajali, Vahid
    Haghani, Masoud
    Vaziri, Zohreh
    Moosazadeh, Mahmmod
    Shabani, Mohammad
    JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 59 : 276 - 283
  • [39] Relationship between lipoprotein lipase and peroxisome proliferator-activated receptor-α expression in rat liver during development
    Panadero, M.
    Bocos, C.
    Herrera, E.
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2006, 62 (03) : 189 - 198
  • [40] Agonists for the peroxisome proliferator-activated receptor-α and the retffionid X receptor inhibit inflammatory responses of microglia
    Xu, JH
    Storer, PD
    Chavis, JA
    Racke, MK
    Drew, PD
    JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 81 (03) : 403 - 411